Tools & Technology
The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.
All children and adolescents with cancer in Ireland, including those who relapse following treatment, will be offered enrollment in the project.
Tempus Signs $200M Deal With AstraZeneca, Pathos AI to Develop Multimodal Cancer Foundation Model
The collaboration, under which Tempus will collect data licensing and model development fees, will leverage its repository of de-identified multimodal patient data.
Biostate AI, Weill Cornell Partner on Leukemia Precision Medicine Project
The partners aim to develop AI models to stratify AML subtypes, make disease prognoses, and help select personalized therapies.
ConcertAI, Bayer Partner to Leverage Patient Data for Precision Oncology Insights
The firms will explore molecular mechanisms and patient responses in cancer to inform development of new therapies.
Invivoscribe's LabPMM Nabs NY State Approval for MRD Assay
The company can now offer the FLT3 ITD MRD Assay in New York state to assess measurable residual disease to guide treatment for acute myeloid leukemia patients.